From Biomarkers to Breakthroughs: Advancing Lung Cancer Research
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Disease Biomarker".
Deadline for manuscript submissions: 15 March 2026 | Viewed by 62
Special Issue Editors
Interests: cancer; lung cancer; immunotherapy; immune-related adverse events
Special Issues, Collections and Topics in MDPI journals
Interests: lung cancer; COPD; asthma; thrombosis; respiratory diseases; pulmonology
Special Issue Information
Dear Colleagues,
Lung cancer remains the leading cause of cancer-related mortality worldwide, with significant unmet clinical needs across diagnosis, prognosis, and treatment. Over the past few decades, substantial advances have been made in identifying molecular biomarkers, paving the way for more personalized and targeted therapeutic approaches.
This Special Issue, entitled “From Biomarkers to Breakthroughs: Advancing Lung Cancer Research,” aims to bring together cutting-edge research and clinical insights that span the continuum from biomarker discovery to translational applications. We invite contributions that explore novel diagnostic markers, predictive and prognostic tools, molecular targets, and resistance mechanisms in both non-small cell and small cell lung cancer.
Original research articles, comprehensive reviews, and real-world data analyses are welcome, particularly those that highlight multidisciplinary strategies, integrate omics data, or examine patient-centered approaches to precision oncology. Our goal is to foster a deeper understanding of the molecular underpinnings of lung cancer and support the ongoing evolution of individualized patient care.
We look forward to your contributions to this timely and impactful collection.
Prof. Dr. Konstantinos Syrigos
Guest Editor
Dr. Marousa Kouvela
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- biomarkers
- personalized medicine
- molecular diagnostics
- targeted therapy
- non-small cell lung cancer
- small cell lung cancer
- resistance mechanisms
- translational research
- precision oncology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
